A new prognostic classification for predicting survival in patients with hepatocellular carcinoma

Journal of Hepatology

Volumn 31, Issue 1, 1999, Pages 133-141

  Chevret, Sylvie ^a   Trinchet, Jean Claude ^b   Mathieu, Didier ^c   Rached, Antoine Abou ^b   Beaugrand, Michel ^b   Chastang, Claude ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Classification; Cox model; Hepatocellular carcinoma; Prediction; Survival

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; BILIRUBIN; TUMOR MARKER;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; ECHOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN OBSTRUCTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE; VALIDATION PROCESS;

EID: 0033066135     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80173-1     Document Type: Article

References (37)

1. Colombo M. Hepatocellular carcinoma in cirrhotics. Semin Liver Dis. 13:1993;374-383.
2. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer. 54:1984;1461-1465.
3. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis. A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology. 16:1992;132-137.
4. Cottone M, Virdone R, Fusco G, Orlando A, Turri M, Caltagirone M, et al. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment. Gastroenterology. 96:1989;1566-1571.
5. Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology. 90:1986;289-298.
6. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 56:1985;918-928.
7. Chlebowski RT, Tong M, Weissman J, Block JB, Ramming KP, Weiner JM, et al. Hepatocellular carcinoma: diagnostic and prognostic features in North American patients. Cancer. 53:1984;2701-2706.
8. Attali P, Prod'homme S, Pelletier G, Papoz L, Ink O, Buffet C, et al. Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival. Cancer. 59:1987;2108-2111.
9. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res. 48:1988;7314-7318.
10. Calvet X, Bruix J, Gines P, Bru C, Sole M, Vilana R, et al. Prognostic factors of hepatocellular carcinoma in the West. A multivariate analysis in 206 patients. Hepatology. 12:1990;753-760.
11. Akashi Y, Koreeda C, Enomoto S, Uchiyama S, Mizuno T, Shiozaki Y, et al. Prognosis of unresectable hepatocellular carcinoma. An evaluation based on multivariate analysis of 90 cases. Hepatology. 14:1991;262-268.
12. Rosellini SR, Arienti V, Nanni O, Ugenti F, Tassinari M, Camporesi C, et al. Hepatocellular carcinoma: prognostic factors and survival analysis in 135 Italian patients. J Hepatol. 16:1992;66-72.
13. Okada S, Okazaki N, Nose H, Yoshimori M, Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology. 16:1992;112-117.
14. Colleoni M, Bajetta E, Nelli P, Boni L, Bochicchio AM, Nole F, et al. Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy. The experience of the National Cancer Institute of Milan. Ann Oncol. 4:1993;489-493.
15. Mels GC, Leandro G, Scorpiniti A, Cristini P, Angeli G. Natural history of hepatocellular carcinoma in Northern Italy. Multivaried analysis of prognostic factors. J Exp Clin Cancer Res. 12:1993;101-106.
16. Razafimahaleo A, Burtin P, Joly JP, Dupas JL, Capron-Chivrac D, Capron JP. Facteurs pronostiques du carcinome hépatocellulaire: analyse multifactorielle de 84 cas. Gastroenterol Clin Biol. 17:1993;564-569.
17. Stillwagon GB, Order SE, Guse C, Leibel SA, Asbell SO, Klein JL, et al. Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01. Int J Radiat Oncol Biol Phys. 20:1991;65-71.
18. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States: prognostic features, treatment, outcome, and survival. Cancer. 77:1996;2217-2222.
19. Arii S, Okamoto E, Imamura M, the Liver Cancer Study Group of Japan. Registries in Japan: Current Status of hepatocellular Carcinoma in Japan. Semin Surg Oncol. 12:1996;204-211.
20. The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 28:1998;751-755.
21. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophagal varices. Br J Surg. 60:1973;646-649.
22. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 106:1994;720-727.
23. Braitman LE, Davidoff F. Predicting clinical states in individual patients. Ann Intern Med. 125:1996;406-412.
24. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. Comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 332:1995;1256-1261.
25. Sheu J, Sung J, Chen D, Yang P, Lai M, Lee C, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology. 89:1985;259-266.
26. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alphafoetoprotein levels: analysis of 606 patients. Cancer. 64:1989;1700-1707.
27. Nishimori H, Tsukishiro T, Nambu S, Okada K, Shimizu Y, Miyabayashi C, et al. Analyses of proliferating cell nuclear antigenpositive cells in hepatocellular carcinoma: comparisons with clinical findings. J Gastroenterol Hepatol. 9:1994;425-432.
28. Chapel F, Guettier C, Chastang C, Abou Rached A, Mathieu D, Tepper M, et al. Needle biopsy of hepatocellular carcinoma. Assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Cancer. 77:1996;864-871.
29. Cottier M, Jouffre C, Maubon I, Sabido O, Barthelemy C, Cuilleron M, et al. Prospective flow cytometric DNA analysis of hepatocellular carcinoma specimens collected by ultrasoundguided fine needle aspiration. Cancer. 74:1994;599-605.
30. Ng IOL, Lai ECS, Ho JCW, Cheung LKN, Ng MMT, So MKP. Flow cytometric analysis of DNA ploidy in hepatocellular carcinoma. Am J Clin Pathol. 102:1994;80-86.
31. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 20:1994;65-71.
32. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 325:1991;675-680.
33. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 334:1996;693-699.
34. Dusheiko GM, Hobbs KEF, Dick R, Burroughs AK. Treatment of small hepatocellular carcinomas. Lancet. 340:1992;285-288.
35. CLIP group . Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. Lancet. 352:1998;17-20.
36. Bruix J. Treatment of hepatocellular carcinoma. Hepatology. 25:1997;259-262.
37. Trinchet JC, Beaugrand M. Treatment of hepatocellular carcinoma in patients with cirrhosis. J Hepatol. 27:1997;756-765.